SCHEMBL7411536

SCHEMBL7411536

COC(=O)c1ccc(NC(C)=O)cc1OC(C)=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.69
SMN1; SMN2 Q16637 4/20 0.65
CDK1 P06493 1/20 0.56
NPC1 O15118 1/20 0.47
PKM P14618 1/20 0.47
RAB9A P51151 1/20 0.47
ALDH1A1 P00352 4/20 0.46
KDM4E B2RXH2 4/20 0.46
HPGD P15428 1/20 0.46
CASP1 P29466 1/20 0.46
CASP7 P55210 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
TOP1 P11387 1/20 0.44
POLB P06746 1/20 0.44
MAPK1 P28482 1/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C19 P33261 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10334194 0.88 SMN1; SMN2 (0.60) TDP1SMN1; SMN2CDK1NPC1PKM
SCHEMBL2555975 0.87 TDP1 (0.73) TDP1SMN1; SMN2CDK1ALDH1A1KDM4E
SCHEMBL7155169 0.86 KDM4E (0.61) TDP1SMN1; SMN2PKMALDH1A1KDM4E
SCHEMBL6535486 0.85 TDP1 (0.52) TDP1SMN1; SMN2CDK1NPC1PKM
SCHEMBL7199385 0.84 HSD17B10 (0.56) TDP1SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL15056471 0.83 TDP1 (0.50) TDP1SMN1; SMN2CDK1NPC1PKM
Ethopabate SCHEMBL29625103 0.82 TDP1 (1.00) TDP1SMN1; SMN2CDK1RAB9AALDH1A1
Ethopabate SCHEMBL540932 0.82 TDP1 (1.00) TDP1SMN1; SMN2CDK1RAB9AALDH1A1
SCHEMBL8137802 0.82 SMN1; SMN2 (0.75) TDP1SMN1; SMN2CDK1NPC1RAB9A
SCHEMBL9391354 0.81 ALDH1A1 (0.59) SMN1; SMN2NPC1PKMRAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1222187-A2 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TYROSINE KINASES BOEHRINGER INGELHEIM PHARMACEUTICALS INC. (US) 2002-07-17 EP disclosed
EP-0865281-B1 NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS BERLEX LAB (US) 2002-04-03 EP disclosed
WO-2001025238-A2 HETEROCYCLIC COMPOUNDS USEFUL AS INHIBITORS OF TYROSINE KINASES BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. (US) 2001-04-12 WO disclosed
EP-0865281-A4 NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS BERLEX LAB (US) 1999-07-28 EP disclosed
US-5849759-A Naphthyl-substituted benzimidazole derivatives as anti-coagulants BERLEX LABORATORIES, INC. (US) 1998-12-15 US disclosed
EP-0865281-A1 NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS BERLEX LABORATORIES, INC. (US) 1998-09-23 EP disclosed
WO-1997021437-A1 NAPHTHYL-SUBSTITUTED BENZIMIDAZOLE DERIVATIVES AS ANTICOAGULANTS BERLEX LABORATORIES, INC. (DE) 1997-06-19 WO disclosed
US-4935511-A Nervous system, gastrointestinal disorders RORER PHARMACEUTICAL CORPORATION (US) 1990-06-19 US disclosed